Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. doi: 10.1002/14651858.CD004185.pub2
Methods Six-week randomised, double-blind study.
Participants Outpatients fulfilling DSM-III-R criteria for non-psychotic depressive episode (no longer than 5 months), with a score of at least 21 on the HDRS and no more than 2 previous antidepressive drugs given for the current episode and no medication for 3-5 days before first assessment.
Age range: 25-50 years old.
Exclusion criteria: psychotic state, significant past head injury, severe neurological disease of physical illness, history of drug addiction or alcoholism, ECT in the last year, suicide risk, or suicide attempt in the last year
Interventions Fluoxetine: 8 participants.
Desipramine: 9 participants.
Fluoxetine dose: 20 mg/day.
Desipramine dose range: 125-200 mg/day.
Outcomes Hamilton Rating Scale for Depression (HDRS-17), CGI.
Notes Funding: unclear
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear